Decision coincides with Pfizer clinical trials on safety and efficacy of vaccine among children aged six months to 12 years, will be administered to those considered high risk; team for handling epidemics also okays third shot for residents of nursing homes as national infection rate hits 0.9%

Health Ministry says number of cases has topped 4,000 in surge largely attributed to highly contagious Delta strain, with almost all patients showing mild or very mild symptoms; Jerusalem health official reports high turnout for vaccines across all age ranges amid fears over new variant

Head of Sheba Medical Center praises Abraham Accords for 'unique opportunity to cooperate in healthcare services'; Memorandum of Understanding enables Israel and UAE to cooperate on cutting-edge research, improve services for patients in several fields, including telemedicine, use of AI

HMOs informed they can administer booster shot to immunocompromised adults after health minister says Israel would move ahead even before U.S. and European regulators approve Pfizer request; ministry recommends giving third dose no less than four weeks after second

Israel Institute for Biological Research collaborates with U.S.-based NRx Pharmaceuticals to bring the country's vaccine candidate, which has been undergoing early clinical trials in recent months, to the global stage